GBP6 and head and neck squamous cell carcinoma: Meanwhile, low expression of GBP6/7 levels in head and neck squamous cell carcinoma (HNSCC) correlates with shorter survival, indicating possible tumor-suppressing activity in specific contexts, while its cytoplasmic vesicle localization hints at roles in immune regulation or vesicular trafficking [51,52].